ProCE Banner Activity

Renal Cell Carcinoma: Update on Clinical Data, Trials, and Guidance for Community Practice

Slideset Download
Download these expert-selected slides on treatments for early and later-stage renal cell carcinoma.

Released: October 21, 2022

Expiration: October 20, 2023

Share

Faculty

Katy Beckermann

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Naomi B. Haas

Naomi B. Haas, MD

Professor
Division of Hematology/Oncology
Director
Kidney Cancer and Prostate Cancer Clinical Research Programs
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Eric Jonasch

Eric Jonasch, MD

Assistant Professor, Genitourinary Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Elizabeth Plimack

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Eisai

Exelixis, Inc.

Merck Sharp & Dohme Corp.

Faculty Disclosure

Primary Author

Katy Beckermann, MD, PhD

Assistant Professor of Medicine
Vanderbilt University Medical Center
Nashville, Tennessee

Katy Beckermann, MD, PhD: consultant/advisor/speaker: Alpine Bioscience, Aravive, AstraZeneca, Aveo, BMS, Exelixis, Merck, Seagen, Sanofi. Research (paid to institution): Aravive, Arsenal, Pionyr

Naomi B. Haas, MD

Professor
Division of Hematology/Oncology
Director
Kidney Cancer and Prostate Cancer Clinical Research Programs
Abramson Cancer Center
University of Pennsylvania
Philadelphia, Pennsylvania

Naomi Haas, MD: consultant/advisor/speaker: Aveo, Eisai, Merck, Roche/Genentech.

Eric Jonasch, MD

Assistant Professor, Genitourinary Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, Texas

Eric Jonasch, MD: : Aravive, Aveo, Calithera, DAVA Oncology, Eisai, Exelixis, Genentech, Ipsen, Merck, NiKang, Novartis, Takeda; researcher: Arrowhead, Merck, NiKang.

Elizabeth Plimack, MD, MS

Assistant Professor
Associate Member
Medical Oncology
Fox Chase Cancer Center
Philadelphia, Pennsylvania

Elizabeth R. Plimack, MD, MS: consultant/advisor/speaker: Astellas, AstraZeneca, Aveo, Bristol-Myers Squibb, Calithera, EMD Serono, Exelixis, IMV, Infinity Pharma, Janssen, MEI, Merck, Natera, Pfizer, Regeneron, Seattle Genetics; researcher (paid to institution): Astellas, Bristol-Myers Squibb, Genentech, Merck.